Promising Nanotechnology Stocks To Consider – April 17th

by · The Cerbat Gem

OSI Systems, NVE, and Biodexa Pharmaceuticals are the three Nanotechnology stocks to watch today, according to MarketBeat’s stock screener tool. Nanotechnology stocks refer to shares in companies that develop, produce, or utilize technologies manipulating matter at the nanoscale, often aiming to revolutionize industries such as electronics, healthcare, and energy. These stocks offer investors exposure to innovations in materials and processes operating at the molecular level, potentially yielding significant growth as nanotechnology continues to evolve and impact various sectors. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.

OSI Systems (OSIS)

OSI Systems, Inc. designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.

Shares of OSIS stock traded up $5.87 on Thursday, reaching $195.22. 96,515 shares of the company’s stock traded hands, compared to its average volume of 183,246. The business’s 50 day moving average price is $194.81 and its two-hundred day moving average price is $175.08. The company has a market capitalization of $3.28 billion, a P/E ratio of 25.08, a price-to-earnings-growth ratio of 1.81 and a beta of 1.19. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.25 and a current ratio of 1.88. OSI Systems has a 12-month low of $126.57 and a 12-month high of $220.00.

Read Our Latest Research Report on OSIS

NVE (NVEC)

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.

NASDAQ NVEC traded down $0.09 during trading on Thursday, reaching $56.88. 11,895 shares of the company’s stock were exchanged, compared to its average volume of 25,577. The firm has a market capitalization of $275.13 million, a PE ratio of 18.35 and a beta of 1.05. NVE has a fifty-two week low of $51.50 and a fifty-two week high of $89.98. The company’s fifty day simple moving average is $65.75 and its 200-day simple moving average is $73.83.

Read Our Latest Research Report on NVEC

Biodexa Pharmaceuticals (BDRX)

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.

BDRX traded up $0.02 on Thursday, reaching $1.48. 64,849 shares of the company traded hands, compared to its average volume of 590,056. The business has a 50 day moving average price of $2.56. Biodexa Pharmaceuticals has a 52-week low of $1.14 and a 52-week high of $74.00.

Read Our Latest Research Report on BDRX

Recommended Stories